Description
HER2/neu (654-662) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
HER2/neu (654-662) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
Purity | ≥95% |
---|---|
Formula | C42H77N9O11 |
Formula Wt. | 884.12 |
Synonym | ErbB2, EGFR2, CD340 |
Solubility | Soluble in DMSO, DMF, acetonitrile. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Neuraminidase inhibitor.
Triazole; 14-α demethylase inhibitor, potentia...
Src and Abl inhibitor.
Salicylic acid derivative; PPARγ agonist, pote...
Tankyrase inhibitor.
Micronuclei formation inducer, antimitotic, oxi...
Wortmannin analog; PI3K inhibitor.
L-type Ca2+ channel blocker, BK K+ channel modu...
GSK3 and AChE inhibitor, potential σ1 agonist....
Calcineurin inhibitor.
5-Fluorouracil prodrug, pyrimidine nucleoside a...
Indirubin derivative.
Camptothecin analog; topoisomerase I inhibitor,...
Macrocyclic lactone.
MAO and histone demethylase LSD1 inhibitor.
Endogenous purine nucleotide base, required for...
Chk1 inhibitor.
Synthetic ghrelin analog; ghrelin agonist.
Nucleoside (deoxyguanosine) analog; DNA chain t...
Synthetic peptide; FPRL1 agonist.